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The detection and treatment of pericarditis
remains a challenging problem, and the aetiology
is unknown in 40–85% of cases [1,2]. As a result, a
large proportion of cases are labelled idiopathic
pericarditis. The advent of echocardiography has
clariﬁed the deﬁnition from pericarditis to peri-
cardial effusion, which is a standardized entity.
Pericardial effusion may be caused by a wide
variety of infections, including those caused by
Coxiella burnetii [3]. In an effort to reduce this
ratio, we have previously developed [4], on 204
patients hospitalized in Marseilles with pericar-
dial effusion, a diagnostic strategy that mandated
the systematic use of a battery of non-invasive
tests for the diagnosis of benign pericardial
effusion. This allowed reduction of the number
of pericarditis cases classiﬁed as idiopathic when
compared to an intuitive prescription of tests [5].
Q fever was the main reported aetiology in our
experience [4], which is particularly interesting,
because it is a treatable disease. Herein, we
present a 8 years of experience of Q fever peri-
carditis diagnosed with a systematic prescription
kit in cases of pericardial effusion.
MATERIALS AND METHODS
The diagnostic procedure included the following: (i) a ques-
tionnaire with the items underlying conditions (immunosup-
pression, collagen diseases), and epidemiological factors (con-
tacts with toxins, contacts with animals, ingestion of
unpasteurized milk, and travel outside the living area within
6 months); (ii) a list of tests to be performed systematically, as
previously described [4].
The diagnosis was considered to be certain if neoplastic
cells or positive cultures were found in the effusion. In the
absence of invasive procedures, the diagnosis was considered
to be certain if collagen disease or thyroid dysfunction was
diagnosed with the kit tests, if there was a two-fold rise in
antibody titres, or when a titre above a speciﬁc cut-off value
was obtained. In the absence of one of these ﬁndings, patients
with known renal failure, collagen disease, thyroid dysfunc-
tion or neoplastic disease were considered to have these
conditions as the cause of their pericarditis.
RESULTS
The kit was prescribed for 916 patients, and 440
were excluded because they presented myocardi-
tis or dry pericarditis (absence of effusion).
Among 476 included patients (Table 1), 215
(45%) had a ﬁnal aetiological diagnosis: the
aetiology of 113 was highly suspected at ﬁrst
examination, and later conﬁrmed (thyroid
deﬁciency, 12; systemic lupus erythematous, 17;
rheumatoid arthritis, 11; scleroderma, two; can-
cers, 55; and renal insufﬁciency, 16). A deﬁnite
aetiological diagnosis was made in 21 patients
from pericardial ﬂuid analysis. Among 342 pa-
tients considered to have idiopathic pericarditis,
81 beneﬁted from an aetiological diagnosis
(23.6%) by our systematic testing strategy. This
included serological evaluation of serum (C. bur-
netii, 20; Bartonella quintana, one; Francisella tular-
ensis, one; Legionella pneumophila, one; Mycoplasma
pneumoniae, ﬁve; enterovirus IgM, two; parvovirus
IgM, one; inﬂuenza virus, one), viral culture of
throat swabs (enterovirus, 12; inﬂuenza virus,
eight; and adenovirus, one), high levels of antinu-
clear antibodies (>1 ⁄ 400, ﬁve cases), and thyroid-
stimulating hormone (23 abnormal results). In our
cohort of pericardial effusion, C. burnetii repre-
sents the main infectious cause (20 ⁄ 54) and one of
the most important aetiologies (20 ⁄ 81) diagnosed
with our kit strategy. Eight of the cases were
diagnosed in spring, and ﬁve in winter, which
corresponds to our local epidemiology. In one
case, the serological proﬁle was compatible with
chronic infection (high persistent titre of phase I
antibodies). This subgroup mean ± SD age was
51.9 ± 13 years, and 11 patients were male, exactly
the same proportion as in the entire pericardial
effusion group. Speciﬁc epidemiological factors
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such as contacts with animals and ingestion of
unpasteurized milk were noticed in 12 cases
only.
DISCUSSION
Our study has been ongoing for 8 years: this
avoids bias linked to seasonal variations in the
analysis of the prevalence of infectious diseases.
The inclusion of systematic testing in the
kit resulted in the unexpected diagnosis of 20
cases of Q fever. Without the use of the kit,
they would have been classiﬁed as idiopathic.
C. burnetii was found to be the cause of 4.2%
of pericardial effusion cases, 5.8% of idiopathic
cases and 38% of infectious aetiologies. In
this study, Q fever was systematically sought
because C. burnetii had recently been men-
tioned as an aetiological agent of pericarditis [1].
No speciﬁc clinical data have emerged to identify
this aetiology as a speciﬁc clinical entity. Q fever
has a worldwide distribution, but very few cases
of pericarditis have been described, because it is
rarely searched for in those circumstances. In
countries where the prevalence is highest (Spain,
the UK and France), the role of local epidemio-
logical speciﬁcity or the impact of a more active
research in specialized laboratories remain
should be discussed to explain the prevalence.
CONCLUSIONS
Our kit is of great interest for patients, because it
increases the number of treatable diseases such as
Q fever. No speciﬁc criteria allowed to predict this
aetiology in case of effusion: this justiﬁes a
systematic prescription of serological test. Speciﬁc
treatment may shorten the evolution of the dis-
eases and avoid recurrences.
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Table 1. Aetiological diagnosis of
the pericardial effusion cases
Aetiological diagnosis
No. of aetiologies identiﬁed
Total1998–2002 [4] 2003 May 2006 (PR)
Total 204 272 476
Diagnosed 116 99 215 (45%)
Coxiella burnetii 10 10 20 (4.2%)
Seasonal variation (spring, summer, autumn, winter) (8, 3, 4, 5)
Bartonella spp. 1 0 1
Francisella tularensis 0 1 1
Legionella pneumophila 1 0 1
Chlamydia spp., Borellia, Brucella 0 0 0
Mycoplasma pneumoniae 4 1 5
Cases diagnosed in spring, summer, autumn, winter, respectively (2, 0, 3, 0)
Streptococcus pneumoniae 1 2 3
Seasonal variation (spring, summer, autumn, winter) (1, 0, 0, 2)
Citrobacter freundii, Escherichia coli, Staphylococcus aureus 1 3 4
Actinomyces 1 0 1
Cryptococcus 0 1 1
Tuberculosis 3 2 5
Toxoplasmosis 4a 0
Cytomegalovirus 4a 0
Epstein–Barr virus 0 1 1
Herpes virus 0 2 2
Parvovirus B19 0 1 1
Hepatitis C 4a 0
Inﬂuenza virus 1 8 9
Seasonal variation (spring, summer, autumn, winter) (1, 0, 0, 8)
Adenovirus 1 0 1
Enterovirus 8 7 15
Seasonal variation (spring, summer, autumn, winter) (5, 2, 2, 6)
Hypo ⁄hyperthyroidism 20 15 35 (7.3%)
Positive antinuclear antibodies 19 3 22 (4.6%)
Rheumatoid arthritis 8 3 11 (2.3%)
Other autoimmune diseases 2 0 2
Neoplastic diseases 30 28 58 (12.1%)
Renal insufﬁciency 5 11 16 (3.4%)
aModiﬁcation of the criteria for diagnosis with the conclusion of the publication [4] (diagnoses based on positive
IgM serological tests and classiﬁed as ‘possible’ are now considered as undiagnosed) PR: Present report
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